Octreotide (Peptron)

N/A

Report date: 2024/08/08 17:10:05

Base Information

Drug NameOctreotide (Peptron)
Drug Alias NamePT-201
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGrowth hormone releasing factor antagonistsSomatostatin receptor agonists
TargetsSomatostatin receptorGrowth hormone releasing factor
Therapy Area/IndicationsIntestinal Obstruction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPeptron Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoswell Park Cancer Institute
Active IndicationsN/A
Inactive IndicationsIntestinal Obstruction

Other Information

ATC CodeN/A
Related LinksN/A